Budesonide fatty-acid esterification: a novel mechanism prolonging binding to airway tissue. Review of available data
- 30 June 2002
- journal article
- review article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 88 (6) , 609-616
- https://doi.org/10.1016/s1081-1206(10)61893-5
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Pharmacokinetics and systemic activity of fluticasone via Diskus® and pMDI, and of budesonide via Turbuhaler®British Journal of Clinical Pharmacology, 2001
- Nasal retention of budesonide and fluticasone in man: Formation of airway mucosal budesonide‐esters in vivoBritish Journal of Clinical Pharmacology, 2001
- Dose‐proportional pharmacokinetics of budesonide inhaled via Turbuhaler®British Journal of Clinical Pharmacology, 1999
- Systemic availability of budesonide after nasal administration of three different formulations: pressurized aerosol, aqueous pump spray, and powderBritish Journal of Clinical Pharmacology, 1999
- Once-Daily Inhaled Corticosteroids in Mild to Moderate AsthmaDrugs, 1999
- Rationale for Once-Daily Therapy in AsthmaDrugs, 1999
- Biological Esterification of SteroidsEndocrine Reviews, 1998
- Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDIEuropean Respiratory Journal, 1994
- Relationship between lung tissue and blood plasma concentrations of inhaled budesonideBiopharmaceutics & Drug Disposition, 1993
- The naturally occurring C-17 fatty acid esters of estradiol are long-acting estrogensThe Journal of Steroid Biochemistry and Molecular Biology, 1985